ArticleCancer immunology, immunotherapy : CII2019

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.

Diana Llopiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.